-
Loke, P, Orsini, F, Lozinsky, AC, Gold, M, O'Sullivan, MD, Quinn, P, Lloyd, M, Ashley, SE, Pitkin, S, Axelrad, C, et al.
Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
The Lancet Child & Adolescent Health
6(3)
:
171 -184
2022
view publication
-
Lloyd, M, Loke, P, Ashley, S, Lozinsky, A, Orsini, F, Gold, M, O'Sullivan, M, Prescott, S, Allen, K, Pitkin, S, et al.
Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy.
Journal of Allergy and Clinical Immunology
149(2)
:
ab317
2022
view publication
-
Loke, P, Lozinsky, AC, Orsini, F, Wong, LS-Y, Leung, AS-Y, Tham, EH, Lopata, AL, Shek, LP-C, Tang, ML, Su, E-L, et al.
Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study).
BMJ Open
11(7)
:
e044331
2021
view publication
-
Lozinsky, AC, Loke, P, Orsini, F, O’Sullivan, M, Prescott, SL, Gold, MS, Quinn, P, DunnGalvin, A, Tang, ML, Ponsoby, A-L, et al.
Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
BMJ Open
10(9)
:
e035871
2020
view publication
-
Tang, MLK, Lozinsky, AC, Loke, P.
Peanut Oral Immunotherapy State of the Art.
Immunology and Allergy Clinics of North America
40(1)
:
97 -110
2020
view publication